Lang, N.J. ; Schniering, J. ; Porras-Gonzalez, D.L. ; Yang, L. ; De Sadeleer, L.J. ; Jentzsch, R.C. ; Shitov, V.A. ; Zhou, S. ; Ansari, M. ; Agami, A. ; Mayr, C. ; Hooshiar Kashani, B. ; Chen, Y. ; Heumos, L. ; Pestoni, J. ; Molnar, E.S. ; Geeraerts, E.* ; Anquetil, V.* ; Saniere, L.* ; Wögrath, M. ; Gerckens, M. ; Lehmann, M. ; Yildirim, A.Ö. ; Hatz, R.A.* ; Kneidinger, N. ; Behr, J. ; Wuyts, W.A.* ; Stoleriu, M.-G. ; Luecken, M. ; Theis, F.J. ; Burgstaller, G. ; Schiller, H.
     
    
        
Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics in human lung fibrogenesis.
    
    
        
    
    
        
        Sci. Transl. Med. 15, 19:eadh0908 (2023)
    
    
    
      
      
	
	    Pulmonary fibrosis develops as a consequence of failed regeneration after injury. Analyzing mechanisms of regeneration and fibrogenesis directly in human tissue has been hampered by the lack of organotypic models and analytical techniques. In this work, we coupled ex vivo cytokine and drug perturbations of human precision-cut lung slices (hPCLS) with single-cell RNA sequencing and induced a multilineage circuit of fibrogenic cell states in hPCLS. We showed that these cell states were highly similar to the in vivo cell circuit in a multicohort lung cell atlas from patients with pulmonary fibrosis. Using micro-CT-staged patient tissues, we characterized the appearance and interaction of myofibroblasts, an ectopic endothelial cell state, and basaloid epithelial cells in the thickened alveolar septum of early-stage lung fibrosis. Induction of these states in the hPCLS model provided evidence that the basaloid cell state was derived from alveolar type 2 cells, whereas the ectopic endothelial cell state emerged from capillary cell plasticity. Cell-cell communication routes in patients were largely conserved in hPCLS, and antifibrotic drug treatments showed highly cell type-specific effects. Our work provides an experimental framework for perturbational single-cell genomics directly in human lung tissue that enables analysis of tissue homeostasis, regeneration, and pathology. We further demonstrate that hPCLS offer an avenue for scalable, high-resolution drug testing to accelerate antifibrotic drug development and translation.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Idiopathic Pulmonary-fibrosis; Pirfenidone; Deficiency; Nintedanib
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2023
    
 
    
        Prepublished in Year
        0
    
 
    
        HGF-reported in Year
        2023
    
 
    
    
        ISSN (print) / ISBN
        1946-6234
    
 
    
        e-ISSN
        1946-6242
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 15,  
	    Issue: 725,  
	    Pages: 19,  
	    Article Number: eadh0908 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            American Association for the Advancement of Science (AAAS)
        
 
        
            Publishing Place
            1200 New York Ave, Nw, Washington, Dc 20005 Usa
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30202 - Environmental Health
80000 - German Center for Lung Research
30205 - Bioengineering and Digital Health
    
 
    
        Research field(s)
        Lung Research
Enabling and Novel Technologies
    
 
    
        PSP Element(s)
        G-501693-001
G-501600-014
G-501800-810
G-505000-008
G-503800-001
G-501800-820
G-501600-001
G-501600-005
G-505000-007
G-501600-002
    
 
    
        Grants
        Bundesinstitut fur Risikoforschung
Deutsche Forschungsgemeinschaft
German Center for Lung Research
Helmholtz Association
European Respiratory Society
Faculty of Medicine of the Ludwig-Maximilians-University Munich
Bavarian State Ministry of Science and Arts
Chan Zuckerberg Initiative
European Union
    
 
    
        Copyright
        
    
 	
    
    
    
    
        Erfassungsdatum
        2023-12-20